Citius Oncology (CTOR) Balance Sheet

As of Sep 30, 2025 (end of fiscal 2025), Citius Oncology reported total assets of $100.94M and total liabilities of $56.08M. Shareholders' equity was $44.87M, down 2.8% from $46.14M a year earlier. Total debt stood at $3.80M against $3.92M in cash and short-term investments, a net cash position of $124.80K. That puts debt-to-equity at 0.08, compared with 0.08 a year earlier.

Citius Oncology Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Citius Oncology, Inc. (CTOR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022
Current Assets
Cash and Cash Equivalents	3.92	0.00	0.00	0.29
Cash & Short-Term Investments	3.92	0.00	0.00	0.29
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	22.29	8.27	0.00	0.00
Other Current Assets	1.33	2.70	7.73	0.09
Total Current Assets	27.54	10.97	7.73	2.69
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00
Long-Term Investments	0.00	0.00	0.00	67.81
Intangible Assets	73.40	73.40	0.00	40.00
Other Non-Current Assets	73.40	73.40	40.00	40.00
Total Non-Current Assets	73.40	73.40	40.00	40.00
Total Assets	100.94	84.37	47.73	42.69
Current Liabilities
Accounts Payable	13.23	3.71	1.29	0.09
Accrued Liabilities	4.09	0.59	0.26	5.75
Other Current Liabilities	32.16	0.00	19.76	0.03
Total Current Liabilities	49.49	32.70	21.05	0.03
Non-Current Liabilities
Long-Term Debt	3.80	3.80	0.00	0.00
Deferred Tax Liabilities	2.78	1.73	0.00	0.58
Other Non-Current Liabilities	2.78	0.00	1.15	0.58
Total Non-Current Liabilities	6.59	5.53	1.15	0.58
Total Liabilities	56.08	38.23	22.20	6.42
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00
Retained Earnings	-64.04	-39.28	-18.13	0.35
Additional Paid-in Capital	108.90	85.41	43.66	41.69
Shares Outstanding	83.51	71.55	71.24	71.24
Total Stockholders' Equity	44.87	46.14	25.54	36.27
Total Liabilities & Equity	100.94	84.37	47.73	42.69

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Citius Oncology Balance Sheet

How much debt does Citius Oncology have?

Citius Oncology had total debt of $3.80M as of Sep 30, 2025, against $3.92M in cash and short-term investments. Its debt-to-equity ratio was 0.08. Total debt was $3.80M a year earlier.

What are Citius Oncology's total assets?

Citius Oncology reported total assets of $100.94M as of Sep 30, 2025, up 19.6% from $84.37M a year earlier. Total liabilities were $56.08M.

What is Citius Oncology's shareholders' equity?

Citius Oncology's shareholders' equity was $44.87M as of Sep 30, 2025, or about $0.54 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition